SELF-BREATHE RCT for Chronic Breathless… | Clinical Trial

Key information

Conditions

Cancer Anemia Anemia, Hemolytic Anemia, Hemolytic, Congenital Anemia, Sickle Cell Asthma Bronchial Diseases Bronchiectasis Adult COPD Chronic Disease Chronic Heart Failure Congenital, Hereditary, and Neonatal Diseases and Abnormalities Cystic Fibrosis Digestive System Diseases Disease Attributes Dyspnea Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genetic Diseases, Inborn Hematologic Diseases Hemic and Lymphatic Diseases Hemoglobinopathies Hepatic Insufficiency Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Infant, Newborn, Diseases Interstitial Lung Disease Kidney Diseases Liver Diseases Liver Failure Lung Diseases Lung Diseases, Interstitial Lung Diseases, Obstructive Male Urogenital Diseases Neoplasms Pancreatic Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Post Covid-19 Pulmonary Disease, Chronic Obstructive Renal Failure Renal Insufficiency Respiration Disorders Respiratory Hypersensitivity Respiratory Tract Diseases Sickle Cell Disease Signs and Symptoms Signs and Symptoms, Respiratory Urogenital Diseases Urologic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

King's College Hospital NHS Foundation TRUST

London, SE5 9RS, United Kingdom

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adults ≥ 18 years of age, with the ability to read and type in English
Access to a computer, or tablet or smart phone, with internet access and the ability to email
Chronic breathlessness (CB) defined as; breathlessness that persists (>3months) despite optimal pharmacological treatment of the underlying disease including cancer, chronic obstructive pulmonary disease (COPD),asthma, interstitial lung disease (ILD), bronchiectasis, cystic fibrosis (CF) chronic heart failure (CHF), sickle cell disease, chronic renal/ liver failure or post COVID-19
Chronic breathlessness at rest or on exertion; MRC dysponea score >2
Willing to engage with short-term self-guided internet-based breathlessness intervention (SELF-BREATHE)
Able to provide informed consent

Exclusion criteria

Breathlessness of unknown cause
A primary diagnosis of chronic hyperventilation syndrome
Currently participating in a rehabilitation programme, e.g. pulmonary/cardiac rehabilitation

Treatment and study plan

SELF-BREATHE

Other

A self -guided, internet -based intervention for patients with chronic breathlessness

Primary outcomes

Feasibility: the number of patients recruited into this study over a 12-month period

Time frame: 12 months

The number of patients recruited into this study over a 12-month period

Sponsors and collaborators

Lead sponsor

King's College Hospital NHS Trust

Other

Collaborators

King's College London

Registry information

Official study title

A Self - Guided, Internet - Based Intervention for Patients With Chronic Breathlessness (SELF-BREATHE): Feasibility Randomised Controlled Trial

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: Oct 5, 2020
Registry last updated: Mar 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed